Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 521 - Heterocyclic compounds containing unspecified hetero rings
Patents for C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)
06/2010
06/24/2010US20100160343 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4
06/24/2010US20100160341 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4
06/23/2010CN1910176B Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
06/22/2010US7741485 3-[4-Chloro-2-fluoro-5-{[isopropyl(methyl)amino]carbonylaminosulfonyl}phenyl]-1-methyl-2,4-dioxo-6-trifluoromethyl-1,2,3,4-tetrahydropyrimidine; crop protection agent
06/22/2010US7741328 Treating inflammatory diseases such as rheumatoid arthritis, multiple sclerosis or Crohn's disease; Very Late Antigen-4 (VLA-4), also called alpha 4 beta 1 integrin; N-(sulfonamido-substituted pyrimidyl, pyridyl or pyrazyl)-L-4-(N,N-dimethylcarbamyloxy)phenylalanine compounds
06/22/2010CA2382355C Oxazole and thiazole derivatives as neurotrophin production/secretion promoting agent
06/17/2010US20100152167 Pyrimidine derivatives
06/10/2010WO2010063069A1 Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals
06/10/2010CA2745495A1 Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals
06/01/2010US7727982 N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide; potent and highly selective inhibitors; coagulation disorders; antithrombotic agents; diagnostic reagents; good bioavailability and/or solubility
06/01/2010US7727981 monoamidino-containing compounds having good bioavailability and/or solubility, used as potent and specific inhibitors of blood coagulation in mammals, and as therapeutic agents for disease states characterized by coagulation disorders
06/01/2010CA2415169C Novel c-4 substituted retinoids
05/2010
05/26/2010EP1461325B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/26/2010CN1489580B 咪唑衍生物 Imidazole derivatives
05/26/2010CN1391469B Npyy5拮抗剂 Npyy5 antagonist
05/25/2010US7723267 Substituted fluoroalcoxyphenylsulfonylurea
05/25/2010US7723266 Such as N-(4,6-dimethoxy-pyrimidin-2-yl)-N'-(2-ethoxy-6-methyl-phenylsulphonyl)-urea; activity; crop plant safety; synthesis
05/25/2010CA2462922C Reverse-turn mimetics and method relating thereto
05/19/2010CN1962417B Stabilized hydroxylamine solutions
05/18/2010CA2465247C Benzimidazoles and analogues and their use as protein kinases inhibitors
05/18/2010CA2422371C Pyrazole compounds useful as protein kinase inhibitors
05/18/2010CA2422367C Pyrazole compounds useful as protein kinase inhibitors
05/18/2010CA2387536C Rate-controlled particles
05/12/2010CN101704810A Cycloalkyl inhibitors of potassium channel function
05/11/2010CA2422299C Triazole compounds useful as protein kinase inhibitors
05/11/2010CA2410177C Thrombin receptor antagonists
05/06/2010US20100113435 Inhibitors of 11-beta-hydroxy steriod dehydrogenase type 1
05/04/2010US7709637 5-phenylpyrimidines, their preparation, intermediates for their preparation, and their use for controlling harmful fungi
05/04/2010US7709480 2-(3,4-dichlorophenylamino)-4-thiocyanato-5-nitro-pyrimidine; 2-chloro-4-(2-acetylamino-ethylamino)-5-trifluoromethyl-pyrimidine; lung cancer
05/04/2010CA2439001C Water-soluble triazole antifungal agents
04/2010
04/29/2010US20100105683 Compounds useful for inhibiting chk1
04/27/2010CA2422378C Pyrazole compounds useful as protein kinase inhibitors
04/20/2010USRE41254 Synthesis procedure for biphenylimidazolyl-(1)-phenylmethane and related compounds
04/20/2010USRE41252 Peptidyl prodrugs and linkers and stabilizers useful therefor
04/20/2010US7700775 Drug delivery
04/20/2010CA2494067C Hetero biaryl derivatives as matrix metalloproteinase inhibitors
04/15/2010DE102008051412A1 New alkyl amine compounds, useful as a catalyst for fluoro-halo exchange of halo-substituted aromatic compounds, and for producing medicaments e.g. chemotherapeutics, agrochemicals and liquid crystals
04/14/2010EP1692144B1 Organometallic transition metal compound, biscyclopentadienyl ligand system, catalyst system and preparation of polyolefins
04/13/2010US7696214 Confining solid tumors; administering a tyrosine kinase inhibitor as antitumor agents; 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline
04/13/2010CA2432303C Pyrazole compounds useful as protein kinase inhibitors
04/13/2010CA2422377C Pyrazole compounds useful as protein kinase inhibitors
04/07/2010EP1590340B1 Inhibitors of histone deacetylase
04/07/2010EP1527050B1 Quinoline derivatives and their use as mycobacterial inhibitors
04/06/2010US7691853 Pyrazole compounds useful as protein kinase inhibitors
04/06/2010CA2361057C Quinoline derivatives and quinazoline derivatives
04/01/2010US20100081686 Pyridone derivatives having a binding activity to the cannabinoid type 2 recepter
04/01/2010US20100081670 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
03/2010
03/31/2010EP2168962A2 Phenylacetamides and their use as glucokinase modulators
03/31/2010EP1546107B1 Cox-2 inhibiting pyridine derivatives
03/30/2010US7687525 e.g. N-(2-aminophenyl)-4-(N-benzoylaminomethyl)benzamide hydrochloride; anticarcinogenic, antitumor agents; hematologic malignancy and a solid carcinoma; autoimmune disease, skin disorders;
03/24/2010EP1751104B1 Synthesis methods and intermediates for the manufacture of rizatriptan
03/24/2010CN101679220A inhibitors of histone deacetylase
03/17/2010EP2163546A1 Quinazoline derivatives
03/17/2010CN101671335A Cytotoxins, prodrugs, linkers and stabilizers useful therefor
03/02/2010US7671074 Have an affinity for the gabapentin binding site and can be used to treat conditions such as pain, epilepsy, migraine and others; N-{amino-[pyridin-2-yl-methyl)-amino]-methylene}-4-methylbenzenesulfonamide
03/02/2010US7671051 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
03/02/2010US7671049 1-{3-[(6-amino-5-nitropyridin-2-yl)amino]propyl}-4-(2,4-dichlorophenyl)-N-[(1S)-2-hydroxy-1-methylethyl]-1H-pyrrole-3-carboxamide; Antidiabetic, hypotensive, antiischemic, anticarcinogenic agents; Alzheimer*s disease, obesity, polycystic ovary syndrome; brain, neurodegenerative and autoimmune diseases
02/2010
02/25/2010US20100048565 Benzimidazole derivatives
02/25/2010DE102008041491A1 Preparing a colorless ionic liquid comprises reaction of heteroatom containing compound with quaternizing agent, where at least one heteroatom act as electron pair
02/18/2010US20100041656 Novel amide derivatives and medicinal use thereof
02/16/2010US7662825 2,3-Dichloro-N-(3-methoxy-5-methyl-2-pyrazinyl)-benzenesulphonamide; inflammatory diseases, such as asthma
02/16/2010CA2478183C Substituted amides
02/16/2010CA2442882C Sulphones which modulate the action of gamma-secretase
02/16/2010CA2381009C Substituted thienyl(amino)sulfonylureas
02/09/2010CA2192092C Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors
02/02/2010CA2418868C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
02/02/2010CA2349903C Ionic liquids ii
02/02/2010CA2315205C Substituted 2-aryl-4-amino-quinazolines, methods for the prodution ans use thereof as medicaments
02/02/2010CA2294809C Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same
01/2010
01/26/2010US7652141 Immunosuppressants, analgesics, antiinflammatory agents
01/26/2010US7652054 Gastrointestinal disorders; cardiovascular disorders; dyspepsia;anticancer agents; antiulcer agents
01/26/2010US7652006 Substituted 1(2H)-phthalazinones and pharmaceutical compositions thereof
01/20/2010EP1202961B1 Arylsulfonamido-substituted hydroxamic acid derivatives
01/19/2010CA2413000C Five-membered ring compounds
01/13/2010EP1144388B1 Acyl derivatives which treat vla-4 related disorders
01/12/2010CA2192089C Inhibitors of interleukin-1.beta. converting enzyme
01/07/2010US20100004241 Non-imidazole aryloxyalkylamines
01/06/2010EP2139850A1 Inhibitors of histone deacetylase
01/06/2010CN101619057A N-substituted piperidine derivatives as serotonin receptor agents
01/05/2010CA2426457C Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
12/2009
12/31/2009US20090326026 Tricyclic Compounds Useful as Angiotensin II Agonists
12/30/2009CN100575345C Pyridone derivative having affinity for cannabinoid 2-type receptor
12/29/2009USRE41065 Such as (6,7-dimethoxyquinazolin-4-yl)-(3-ethynylphenyl)-amine for treatment of hyperproliferative diseases
12/29/2009US7638546 Imidazolyl derivatives
12/29/2009CA2466490C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
12/29/2009CA2428133C Indolylmaleimide derivatives as protein kinase c inhibitors
12/24/2009US20090318703 Carboxylic acid derivatives and pharmaceutical agent comprising the same as active ingredient
12/24/2009US20090318463 Indolylmaleimide Derivatives
12/23/2009EP1523475B1 Heterocyclically substituted benzoylureas, method for their production and their use as medicaments
12/22/2009US7635774 Benzimidazole derivatives
12/22/2009CA2434813C Imidazole derivatives
12/22/2009CA2346563C Novel 2-[3-phenyl-2-propenyl]-1,2,3,4-tetrahydroxyisoquinoline derivatives, preparation method and use as fungicides
12/22/2009CA2262435C Preparation of sterically hindered amine ethers
12/17/2009US20090312543 Pyrazole compounds useful as protein kinase inhibitors
12/17/2009US20090312307 Heterocyclo inhibitors of potassium channel function
12/15/2009CA2388320C N-substituted carbamoyloxyalkyl-azolium derivatives
12/09/2009EP1300401B1 Thiazole derivatives for use as antiinflammatories
12/09/2009EP1020179B1 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition
12/08/2009CA2422354C Pyrazole compounds useful as protein kinase inhibitors
12/08/2009CA2422342C Novel amide derivatives and medicinal use thereof
1 2 3 4 5 6 7 8 9 10 11 12 13 14 ... 163